Company / Working Capital per Share
Vaxcyte, Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$10.45
FY2025
5-year range
$4.38 / $13.90
FY2021-FY2025
Trend
-22.7%
vs FY2024
Sector context
#45 of 210
Health Care
What the data says
Vaxcyte, Inc.'s working capital per share of $10.45 is higher than 79% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 7 years, ranging from $4.38 in FY2021 to $13.90 in FY2022.
Based on SEC 10-K filings.
10.45 in FY2025 with a 5-year CAGR of -2.0%. Top quartile in the Health Care sector.
Improved from $9.78 to $10.45 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -9.1%
- 5-Year CAGR
- -2.0%
- 10-Year CAGR
- -
Sector benchmark
-92.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 22.7% year-over-year.
- Ranks #45 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.45 | -22.7% |
| FY2024 | $13.51 | +38.0% |
| FY2023 | $9.78 | -29.6% |
| FY2022 | $13.90 | +217.1% |
| FY2021 | $4.38 | -62.1% |
| FY2020 | $11.58 | -13.3% |
| FY2019 | $13.35 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026